Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 7 (2010), Issue 7 (July)

1. Sexual abuse and lifetime diagnosis of psychiatric disorders: systematic review and meta-analysis.
   Mayo Clin Proc, 85(7): 618-29. [Abstract] [Full-text]
2. Effect of absorption site on the pharmacokinetics of sublingual asenapine in healthy male subjects.
   Biopharm Drug Dispos, 31(5): 351-7. [Abstract] [Full-text]
3. NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.
   J Clin Invest, 120(7): 2432-45. [Abstract] [Full-text]
4. Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses.
   BMC Psychiatry, 10: 39. [Abstract] [Full-text]
5. Psychiatric disorders and treatment in low-income pregnant women.
   J Womens Health (Larchmt), 19(7): 1251-62. [Abstract] [Full-text]
6. A review of hyperprolactinaemia and severe mental illness: are there implications for clinical biochemistry?
   Ann Clin Biochem, 47: 292-300. [Abstract] [Full-text]
7. Unplanned versus planned suicide attempters, precipitants, methods, and an association with mental disorders in a Korea-based community sample.
   J Affect Disord. [Abstract] [Full-text]
8. Obsessive-compulsive disorder and cyclothymic temperament: An exploration of clinical features.
   J Affect Disord. [Abstract] [Full-text]
9. Effects of asenapine, olanzapine, and risperidone on psychotomimetic-induced reversal-learning deficits in the rat.
   Behav Brain Res. [Abstract] [Full-text]
10. Gender differences in immediate memory in bipolar disorder.
    Psychol Med, 40(8): 1349-55. [Abstract] [Full-text]
11. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Psychol Med, 40(8): 1337-47. [Abstract] [Full-text]
12. Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study.
    Am J Psychiatry, 167(7): 792-800. [Abstract] [Full-text]
13. The expression of the transcription factor FEV in adult human brain and its association with affective disorders.
    J Neural Transm, 117(7): 831-6. [Abstract] [Full-text]
14. Serotonin 1A receptor gene, schizophrenia and bipolar disorder: An association study and meta-analysis.
    Psychiatry Res. [Abstract] [Full-text]
15. Neuropsychological factors differentiating treated children with pediatric bipolar disorder from those with attention-deficit/hyperactivity disorder.
    J Clin Exp Neuropsychol. [Abstract] [Full-text]
16. A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
17. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder.
    Biol Psychiatry, 68(2): 156-62. [Abstract] [Full-text]
18. Consanguinity and increased risk for schizophrenia in Egypt.
    Schizophr Res, 120(1): 108-12. [Abstract] [Full-text]
19. Cross-species assessments of motor and exploratory behavior related to bipolar disorder.
    Neurosci Biobehav Rev, 34(8): 1296-306. [Abstract] [Full-text]
20. Association of NPAS3 exonic variation with schizophrenia.
    Schizophr Res, 120(1): 143-9. [Abstract] [Full-text]
21. Lymphoblast and brain expression of AHI1 and the novel primate-specific gene, C6orf217, in schizophrenia and bipolar disorder.
    Schizophr Res, 120(1): 159-66. [Abstract] [Full-text]
22. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder.
    Biol Psychiatry, 68(1): 41-50. [Abstract] [Full-text]
23. Pushing and coasting in dynamic goal pursuit: coasting is attenuated in bipolar disorder.
    Psychol Sci, 21(7): 1021-7. [Abstract] [Full-text]
24. The impact of premenstrual dysphoric disorder among 92 bipolar patients.
    Eur Psychiatry. [Abstract] [Full-text]
25. Elevated Delta-6 desaturase (FADS2) gene expression in the prefrontal cortex of patients with bipolar disorder.
    J Psychiatr Res. [Abstract] [Full-text]
26. beta-Catenin Promoter ChIP-Chip Reveals Potential Schizophrenia and Bipolar Disorder Gene Network.
    J Neurogenet. [Abstract] [Full-text]
27. Self-reported cognitive problems predict employment trajectory in patients with bipolar I disorder.
    J Affect Disord, 124(3): 324-8. [Abstract] [Full-text]
28. Pituitary volume in patients with bipolar disorder and their first-degree relatives.
    J Affect Disord, 124(3): 256-61. [Abstract] [Full-text]
29. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    J Affect Disord, 124(3): 250-5. [Abstract] [Full-text]
30. The role of valproate in metabolic disturbances in bipolar disorder patients.
    J Affect Disord, 124(3): 319-23. [Abstract] [Full-text]
31. The utility of Mood Disorder Questionnaire for the detection of bipolar diathesis in treatment-resistant depression.
    J Affect Disord, 124(3): 270-4. [Abstract] [Full-text]
32. Reducing the Hypomania Checklist (HCL-32) to a 16-item version.
    J Affect Disord, 124(3): 351-6. [Abstract] [Full-text]
33. Effects of brain-derived neurotrophic factor on sodium-induced apoptosis in human olfactory neuroepithelial progenitor cells.
    Psychiatry Res, 178(2): 391-4. [Abstract] [Full-text]
34. Pregnenolone for cognition and mood in dual diagnosis patients.
    Psychiatry Res, 178(2): 309-12. [Abstract] [Full-text]
35. Computerized ambulatory monitoring in mood disorders: feasibility, compliance, and reactivity.
    Psychiatry Res, 178(2): 440-2. [Abstract] [Full-text]
36. Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder.
    Psychiatry Res, 178(2): 374-80. [Abstract] [Full-text]
37. Altered self-report of empathic responding in patients with bipolar disorder.
    Psychiatry Res, 178(2): 354-8. [Abstract] [Full-text]
38. Default mode network abnormalities in bipolar disorder and schizophrenia.
    Psychiatry Res, 183(1): 59-68. [Abstract] [Full-text]
39. "Folie circulaire" vs "Folie à double forme": Contribution from a French national study.
    Eur Psychiatry. [Abstract] [Full-text]
40. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults.
    J Affect Disord. [Abstract] [Full-text]
41. Voltage-dependent calcium channel and NMDA receptor antagonists augment anticonvulsant effects of lithium chloride on pentylenetetrazole-induced clonic seizures in mice.
    Epilepsy Behav, 18(3): 171-8. [Abstract] [Full-text]
42. Data on schizotypy and affective scales are gender and education dependent--study in the Northern Finland 1966 Birth Cohort.
    Psychiatry Res, 178(2): 408-13. [Abstract] [Full-text]
43. Is elevated norepinephrine an etiological factor in some cases of epilepsy?
    Seizure, 19(6): 311-8. [Abstract] [Full-text]
44. LICAVAL: combination therapy in acute and maintenance treatment of bipolar disorder.
    Trials, 11: 72. [Abstract] [Full-text]
45. Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, double-blind, dose-response study.
    J Affect Disord. [Abstract] [Full-text]
46. Deficits in psychological well-being and quality-of-life in minor depression: implications for DSM-V.
    CNS Neurosci Ther, 16(4): 208-16. [Abstract] [Full-text]
47. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder.
    Pharmacogenet Genomics, 20(8): 500-6. [Abstract] [Full-text]
48. Stereotactic lesions for the treatment of psychiatric disorders.
    J Neurosurg. [Abstract] [Full-text]
49. Downregulation and Upregulation of Glial Connexins May Cause Synaptic Imbalances Responsible for the Pathophysiology of Bipolar Disorder.
    CNS Neurosci Ther. [Abstract] [Full-text]
50. Improving the design of maintenance studies for bipolar disorder.
    Curr Med Res Opin, 26(8): 1835-42. [Abstract] [Full-text]
51. First-dose pharmacokinetics of lithium carbonate in children and adolescents.
    J Clin Psychopharmacol, 30(4): 404-10. [Abstract] [Full-text]
52. The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium.
    J Neurosci, 30(28): 9368-80. [Abstract] [Full-text]
53. Outcome of patients with lithium poisoning at a far-east poison center.
    Hum Exp Toxicol. [Abstract] [Full-text]
54. Event-related Potential Study of the Effects of Emotional Facial Expressions on Task Performance in Euthymic Bipolar Patients.
    Appl Psychophysiol Biofeedback. [Abstract] [Full-text]
55. Bipolar affective disorder associated with thenar hypoplasia: is lithium safe?
    Am J Ther, 17(4): e135-6. [Abstract] [Full-text]
56. Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.
    J Psychiatr Res, 44(11): 688-93. [Abstract] [Full-text]
57. Prevalence and impact of manic traits in depressed patients initiating interferon therapy for chronic hepatitis C infection.
    J Clin Gastroenterol, 44(7): e141-6. [Abstract] [Full-text]
58. Acute camptocormia induced by olanzapine: a case report.
    J Med Case Reports, 4: 192. [Abstract] [Full-text]
59. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Gen Hosp Psychiatry, 32(4): 446.e1-2. [Abstract] [Full-text]
60. Two sides of the same coin: caring for a person with bipolar disorder.
    J Psychiatr Ment Health Nurs, 17(6): 535-42. [Abstract] [Full-text]
61. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Int J Neuropsychopharmacol. [Abstract] [Full-text]
62. Initial depressive episodes affect the risk of suicide attempts in Korean patients with bipolar disorder.
    Yonsei Med J, 51(5): 641-7. [Abstract] [Full-text]
63. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.
    Toxicol Sci, 116(2): 632-9. [Abstract] [Full-text]
64. Basal Ganglia activity in pathological gambling: a fluorodeoxyglucose-positron emission tomography study.
    Neuropsychobiology, 62(2): 132-8. [Abstract] [Full-text]
65. Recurrent factitious subcutaneous emphysema: report of a complex case in a young woman and a literature review.
    Kaohsiung J Med Sci, 26(7): 377-83. [Abstract] [Full-text]
66. Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up.
    Acta Psychiatr Scand. [Abstract] [Full-text]
67. The risk of psychotic symptoms associated with recreational methamphetamine use.
    Drug Alcohol Rev, 29(4): 358-63. [Abstract] [Full-text]
68. Low baseline startle and deficient affective startle modulation in remitted bipolar disorder patients and their unaffected siblings.
    Psychophysiology, 47(4): 659-68. [Abstract] [Full-text]
69. Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder.
    Genes Brain Behav, 9(5): 503-11. [Abstract] [Full-text]
70. Managing Bipolar Youths in a Psychiatric Inpatient Emergency Service.
    Child Psychiatry Hum Dev. [Abstract] [Full-text]
71. Validation of the Norwegian version of the Social Functioning Scale (SFS) for schizophrenia and bipolar disorder.
    Scand J Psychol. [Abstract] [Full-text]
72. Pituitary volume and third ventricle width in euthymic patients with bipolar disorder.
    Psychoneuroendocrinology, 35(7): 1074-81. [Abstract] [Full-text]
73. Psychiatric disorders leading to hospitalization before and after infertility treatments.
    Hum Reprod, 25(8): 2018-23. [Abstract] [Full-text]
74. Factors associated with work, social life and family life disability in bipolar disorder patients.
    Psychiatry Res. [Abstract] [Full-text]
75. The clinician's dilemma: borderline personality disorder or bipolar spectrum disorder?
    Australas Psychiatry, 18(4): 303-8. [Abstract] [Full-text]
76. Sustained attention as a potential endophenotype for bipolar disorder.
    Acta Psychiatr Scand, 122(3): 235-45. [Abstract] [Full-text]
77. Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community.
    Acta Psychiatr Scand, 122(3): 255-66. [Abstract] [Full-text]
78. Influence of medications and diagnoses on fall risk in psychiatric inpatients.
    Am J Health Syst Pharm, 67(15): 1274-80. [Abstract] [Full-text]
79. Increased uric acid levels in drug-naïve subjects with bipolar disorder during a first manic episode.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(6): 819-21. [Abstract] [Full-text]
80. Evaluation of citrate synthase activity in brain of rats submitted to an animal model of mania induced by ouabain.
    Mol Cell Biochem, 341(1): 245-9. [Abstract] [Full-text]
81. Preattentive dysfunction in bipolar disorder: a MEG study using auditory mismatch negativity.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(6): 903-12. [Abstract] [Full-text]
82. Activation of Akt signaling in rat brain by intracerebroventricular injection of ouabain: a rat model for mania.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(6): 888-94. [Abstract] [Full-text]
83. Disturbance in long distance gamma coherence in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(6): 861-5. [Abstract] [Full-text]
84. Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder.
    Psychiatry Clin Neurosci, 64(4): 367-71. [Abstract] [Full-text]
85. Recent research on impulsivity in individuals with drug use and mental health disorders: implications for alcoholism.
    Alcohol Clin Exp Res, 34(8): 1319-33. [Abstract] [Full-text]
86. The clinical significance of creativity in bipolar disorder.
    Clin Psychol Rev, 30(6): 721-32. [Abstract] [Full-text]
87. PROKR2 is associated with methamphetamine dependence in the Japanese population.
    Prog Neuropsychopharmacol Biol Psychiatry, 34(6): 1033-6. [Abstract] [Full-text]
88. Reproductive patterns in psychotic patients.
    Schizophr Res, 121(1): 234-40. [Abstract] [Full-text]
89. Psychiatric diagnoses in patients who screen positive on the Mood Disorder Questionnaire: Implications for using the scale as a case-finding instrument for bipolar disorder.
    Psychiatry Res. [Abstract] [Full-text]
90. Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression?
    J Affect Disord. [Abstract] [Full-text]
91. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.
    Psychiatry Clin Neurosci, 64(4): 341-57. [Abstract] [Full-text]
92. Lithium-mediated protection against ethanol neurotoxicity.
    Front Neurosci, 4: 41. [Abstract] [Full-text]
93. Quetiapine-induced hyperventilation and dyspnea.
    Clin Neuropharmacol, 33(4): 214. [Abstract] [Full-text]
94. Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?
    Drugs Aging, 27(8): 607-15. [Abstract] [Full-text]
95. The role of mental disorders in the risk and speed of transition to alcohol use disorders among community youth.
    Psychol Med. [Abstract] [Full-text]
96. Duration of untreated illness and suicide in bipolar disorder: a naturalistic study.
    Eur Arch Psychiatry Clin Neurosci, 260(5): 385-91. [Abstract] [Full-text]
97. The effect of moderate and excessive alcohol use on the course and outcome of patients with bipolar disorders: a prospective cohort study.
    J Clin Psychiatry, 71(7): 885-893. [Abstract] [Full-text]
98. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? a meta-analysis of the efficacy of rTMS in psychiatric disorders.
    J Clin Psychiatry, 71(7): 873-884. [Abstract] [Full-text]
99. Somatosensory evoked potentials recorded from the human pedunculopontine nucleus region.
    Mov Disord. [Abstract] [Full-text]
100. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
     J Clin Psychiatry, 71(7): 902-909. [Abstract] [Full-text]
101. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood.
     J Clin Psychiatry, 71(7): 864-872. [Abstract] [Full-text]
102. The impact of the Val158Met catechol- O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives.
     Psychol Med. [Abstract] [Full-text]
103. Functional Impairment and Disability across Mood States in Bipolar Disorder.
     Value Health. [Abstract] [Full-text]
104. Potential Adverse Effects of Discontinuing Psychotropic Drugs.
     J Psychosoc Nurs Ment Health Serv. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.